# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-24-132308
Filing Date
2024-12-30
Accepted
2024-12-30 09:10:43
Documents
21
Period of Report
2024-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2432193d1_8k.htm iXBRL | 8-K | 50113
2 | EXHIBIT 3.1 | tm2432193d1_ex3-1.htm | EX-3.1 | 47676
3 | EXHIBIT 4.1 | tm2432193d1_ex4-1.htm | EX-4.1 | 4064
4 | EXHIBIT 10.1 | tm2432193d1_ex10-1.htm | EX-10.1 | 185561
5 | EXHIBIT 10.2 | tm2432193d1_ex10-2.htm | EX-10.2 | 98995
6 | EXHIBIT 99.1 | tm2432193d1_ex99-1.htm | EX-99.1 | 11294
10 | GRAPHIC | tm2432193d1_ex4-1img001.jpg | GRAPHIC | 390278
11 | GRAPHIC | tm2432193d1_ex4-1img002.jpg | GRAPHIC | 95242
12 | GRAPHIC | tm2432193d1_ex99-1img001.jpg | GRAPHIC | 8291
| Complete submission text file | 0001104659-24-132308.txt |  | 1350976

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | kala-20241229.xsd | EX-101.SCH | 3009
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | kala-20241229_lab.xml | EX-101.LAB | 34240
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | kala-20241229_pre.xml | EX-101.PRE | 22355
23 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2432193d1_8k_htm.xml | XML | 3683

Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 241587054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)